70
Participants
Start Date
September 1, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
December 31, 2027
Maraviroc
antiretroviral intensification
Dolutegravir
antiretroviral intensification
Dendritic Cell Vaccine
therapeutic vaccination
Auranofin
purging
Sirtuin Histone deacetylase inhibitor
latency disruption
CCDI, São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
Federal University of São Paulo
OTHER